DEDICATED ONCOLOGY FACILITY

OVERVIEW


State of the Art manufacturing facility (API and formulations) for Oncology and high potent products in compliance with international standards, to come up in two phases (with containment measures)
It is a FDA approvable facility located in 40,500 Sq.m area in JN pharma city in Vizag, India
Can cater to a wide range of processes / products including Lyophilized injections, Liquid injections, Tablets and Capsules
"" Isolator barrier technology is used for safety and minimizing operator exposure levels
"" Dedicated AHUs to prevent cross contamination
"" Facility well positioned to cater to contract manufacturing and joint venture partnerships
SALIENT FEATURES (PHASE 1)
API Block (2600 Sq.m, 26KL)
Formulation Block (2000 Sq.m) (currently under construction)
QA/QC block
"" Utility blocks with all necessary infrastructure
"" In house ETP supported by common effluent treatment plant and hazardous waste management system in pharma city, Vizag
"" Integrated health and safety measures

Phase 2 - Two more API blocks (5800 Sq.m) and an additional formulation block (3000 Sq.m) are planned